Impact of inflation already widespread, but data suggests worse to come
Discussion over PEPP, SGP draw attention to rising yields
Post-Covid era dawns on new landscape for bad debt in Greece
Company closures dropped sharply during the pandemic
Government rolls out red carpet to lure private wealth to Greece
Survey illustrates extent of pandemic impact on firms amid recovery hopes
Greek Pharmaceuticals: The little pill with big potential
The Greek pharmaceutical industry has remained a relatively strong sector despite the crisis - it contributes around 2.8 billion euros to GDP annually, according to the Greek government, and is one of the few industries in Greece which expanded its companies and workforce during the crisis rather than reduced it.
In export terms, Greek medical products (packaged medicaments) come second only to refined petroleum products. With a highly skilled workforce and reliable reputation in the sector, the Greek pharma industry has grounds for expanding its market share in...
If you are already registered, please sign in.
A tailor-made service for professionals
Apart from having access to all our analysis and data, subscribers will be able to consult one-on-one with our analysts.
Read some of our analysis for no charge
By signing up to MacroPolis, readers will be able to read two of our articles without charge each month. They will not have access to our data or weekly e-newsletter.
Our analysis and data at your fingertips
Subscribers will be able to read the full range of our articles, access our statistics and charts, and receive our weekly e-newsletter for €450 per year.€480.00